Global Porcine Epidemic Diarrhea Vaccines Overview
Porcine epidemic diarrhea (PED) is a viral infection that occurs in pigs. Transmission of the disease occurs by close contact between pigs and even by exposure to contaminated body fluids such as semen, virus-contaminated blood, contaminated needles, and many such factors. The symptoms of this disease include watery diarrhea and anorexia. Porcine epidemic vaccines are used to prevent the porcine epidemic diarrhea.
Increasing prevalence of porcine epidemic diarrhea in pigs across the globe is the major driving factor for the global porcine epidemic diarrhea vaccines market growth. According to a data published by United States Department of Agriculture, there are 39 states in the US confirming at least one case of PED since the beginning of the outbreak in 2013. However, unawareness regarding the benefits of porcine epidemic diarrhea vaccines is expected to restrain the global porcine epidemic diarrhea vaccines market growth over the forecast period. Nevertheless, rise in the production of more vaccines to cure porcine epidemic diarrhea is anticipated to create lucrative growth opportunities over the forecast period for the global porcine epidemic diarrhea vaccines market.
The research scope provides comprehensive market size, and other in-depth market information details such as, market growth supporting factors, restraining factors, trends, opportunities, market risk factors, market competition, product and services advancements and launches, product/services related regulations overview, and recent developments for the mentioned forecast period. In addition, the report provides key examination of market players operating in the specific market and analysis and outcomes related with the target market for more than 20 countries.
In the current research scope 2018 is considered as base year and 2019 is estimated year for market value/volume calculations. The report offers market estimates for the forecast period – 2019 to 2029. The report provides factual inputs and analysis based on primary and secondary research, which includes insights gained through in-depth interviews with primary research participants. Also, the data is gathered from authentic secondary sources and is verified by key opinion leaders in the target market. The in-house research is applied on gathered information to provide more accurate data points and reduce the margin of error. The in-house research and analysis efforts include various tools and 360o data analysis methodology.
The global porcine epidemic diarrhea vaccines market report segments the market on the basis of type, application, and region.
The report expected to answer various target market related questions and offers insights on:
- Definition, description, overview of market growth influencing factors, and forecast for the target market
- Scope for related market in the forecast period
- Analysis and outcome for the global porcine epidemic diarrhea vaccines market by segment and region followed by countries
- Market segmentation, dominating segment and region followed by country along with market value, share, Y-o-Y growth, CAGR, forecast, and contribution in the market
- Key market player profiles, their recent developments, strategies, financial details, key competencies, presence by region, and product portfolio
- Valuable insights, data, and forecast that can be referenced to plan business strategies, to tap market opportunities, understand business related risks, derive business goals, to recognize trends, and understand target customers/end users
- Insights on recent technologies, pipeline products, regulations related with target market, market investment, and offers insights on political and economic factors that may influence market growth
- PEST Analysis, PORTER’s five forces analysis, opportunity map analysis, drivers and restraints impact analysis, and market attractiveness index
Key players in the global porcine epidemic diarrhea vaccines market includes:
- Cavac Biomaterials
- Green Cross Veterinary Products Co., Ltd.
- Harrisvaccines, Inc.
- Komipharm International Co., Ltd.
- Nisseiken Co., Ltd.
- Qilu Animal Health Products Factory Co., Ltd.
- Zoetis, Inc.
Prophecy Market Insights offers required customization on this report according to specific business requirements.
Global Porcine Epidemic Diarrhea Vaccines Table of Contents
Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
Market Preview
- Executive Summary
- Key Findings—Global Outlook for medical carts Strategies
- Key Questions this Study will Answer
- Market Snippet, By Type
- Market Snippet, By Application
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restrains
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
Porcine Epidemic Diarrhea Vaccines Market, By Type, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Live Vaccines
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Killed Vaccines
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Porcine Epidemic Diarrhea Vaccines Market, By Application, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Piglets
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Adults Pigs
- Overview
- Market Size and Forecast (US$ Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
Porcine Epidemic Diarrhea Vaccines Market, By Region, Forecast Period up to 10 Years, (US$ Bn)
- Overview
- Market Value and Forecast (US$ Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Regional Trends
- North America
- Market Size and Forecast (US$ Bn), By Type, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Bn), By Type, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Bn), By Type, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Bn), By Type, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Bn), By Type, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (US$ Bn), By Country, Forecast Period up to 10 Years
- GCC
- Israel
- South Africa
- Rest of Middle East
Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
Company Profiles
- Cavac Biomaterials
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Green Cross Veterinary Products Co., Ltd.
- .Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Harrisvaccines, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Komipharm International Co., Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Nisseiken Co., Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Qilu Animal Health Products Factory Co., Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
- Zoetis, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Business Strategies
The Last Word
- Future Impact
- About Us
- Contact
FAQs
The global porcine epidemic diarrhea vaccines market report segments the market on the basis of type, application, and region.
Emerging trends include the development of more effective and innovative vaccines, increased focus on biosecurity measures, and the potential for combination vaccines. Opportunities arise from the ongoing need to control and prevent porcine epidemic diarrhea (PED) in swine populations globally.
Key factors include the economic impact of PED on the swine industry, rising awareness of the importance of vaccination in disease prevention, regulatory support for vaccine development, and a growing emphasis on sustainable and ethical farming practices.
Regions typically considered include North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The dominance of the market may vary based on factors such as the prevalence of PED, pig farming practices, and the adoption of vaccination strategies. Asia-Pacific, especially in countries with large swine populations, may play a significant role in the market.
Cavac Biomaterials, Green Cross Veterinary Products Co., Ltd., Harrisvaccines, Inc., Komipharm International Co., Ltd., Nisseiken Co., Ltd., Qilu Animal Health Products Factory Co., Ltd., Zoetis, Inc.,